Showing results (141-150 of 290) with videos related to
Sort By:
Pageof 29
The Oncologist|September 4, 2015
Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and DifferencesKai Wang, Adrienne Johnson, Siraj M Ali, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2013
Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitorsHelena A Yu, Camelia S Sima, James Huang, et al.The Oncologist|October 31, 2018
Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from TherapyHyunseok Kang, Dean Pettinga, Adrian D Schubert, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2013
BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibitionKatherine E Hutchinson, Doron Lipson, Philip J Stephens, et al.Clinical Genitourinary Cancer|October 5, 2017
Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary SystemSumati Gupta, Daniel Albertson, David Gaston, et al.Cancer Discovery|April 7, 2016
BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination TherapySamuel J Klempner, Bruce Gershenhorn, Phu Tran, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Pharmacokinetics and toxicity of weekly docetaxel in older patientsArti Hurria, Mark T Fleming, Sharyn D Baker, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 4, 2007
A phase II tolerability study of cisplatin plus docetaxel as adjuvant chemotherapy for resected non-small cell lung cancerChristopher G Azzoli, Lee M Krug, Vincent A Miller, et al.JCI Insight|February 15, 2017
Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomesLynn H Lee, Anjelika Gasilina, Jayeeta Roychoudhury, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancerStéphane Vignot, Garrett M Frampton, Jean-Charles Soria, et al.Pageof 29